These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8946952)

  • 1. Nitric oxide released from zwitterionic polyamine/NO adducts inhibits Cu2+-induced low density lipoprotein oxidation.
    Yamanaka N; Oda O; Nagao S
    FEBS Lett; 1996 Nov; 398(1):53-6. PubMed ID: 8946952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea catechins such as (-)-epicatechin and (-)-epigallocatechin accelerate Cu2+-induced low density lipoprotein oxidation in propagation phase.
    Yamanaka N; Oda O; Nagao S
    FEBS Lett; 1997 Jan; 401(2-3):230-4. PubMed ID: 9013893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of high-density lipoprotein subfractions inhibiting copper-catalyzed oxidation of low-density lipoprotein.
    Huang JM; Huang ZX; Zhu W
    Clin Biochem; 1998 Oct; 31(7):537-43. PubMed ID: 9812173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P; Ongsakul M; Proudfoot J; Croft K; Beilin L
    Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrobiopterin inhibits copper-induced oxidation of low density lipoprotein.
    Sakuma S; Fujimoto Y; Gohda Y; Fujita T
    Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):397-406. PubMed ID: 11589366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
    Taniguchi S; Yanase T; Kobayashi K; Takayanagi R; Haji M; Umeda F; Nawata H
    Endocr J; 1994 Dec; 41(6):605-11. PubMed ID: 7704084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR; Loo G
    J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prooxidant activity of caffeic acid, dietary non-flavonoid phenolic acid, on Cu2+-induced low density lipoprotein oxidation.
    Yamanaka N; Oda O; Nagao S
    FEBS Lett; 1997 Mar; 405(2):186-90. PubMed ID: 9089288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of resveratrol on oxidative modification of human low density lipoprotein.
    Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
    Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.
    Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER
    Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Cu2+-induced LDL oxidation by nitric oxide: a study using donors with different half-time of NO release.
    Seccia M; Perugini C; Albano E; Bellomo G
    Biochem Biophys Res Commun; 1996 Mar; 220(2):306-9. PubMed ID: 8645301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B; Volkova N; Rosenblat M; Aviram M
    Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of Isorhamnetin and Hesperidin on LDL oxidation induced by Cu2+].
    Liu R; Meng F; Liu Y; Bai H; Liu BW
    Zhong Yao Cai; 2007 Jun; 30(6):677-81. PubMed ID: 17918439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein.
    Miura S; Watanabe J; Tomita T; Sano M; Tomita I
    Biol Pharm Bull; 1994 Dec; 17(12):1567-72. PubMed ID: 7735196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of quercetin, rutin and puerarin on LDL oxidation induced by Cu2+].
    Liu R; Meng F; Bai H; Liu Y; Tang CW; Liu BW
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2058-62. PubMed ID: 18161305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper.
    Yue TL; McKenna PJ; Lysko PG; Ruffolo RR; Feuerstein GZ
    Atherosclerosis; 1992 Dec; 97(2-3):209-16. PubMed ID: 1361324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein.
    Ohta T; Takata K; Horiuchi S; Morino Y; Matsuda I
    FEBS Lett; 1989 Nov; 257(2):435-8. PubMed ID: 2511042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chelation of copper reduces inhibition by oxidized lipoproteins of endothelium-dependent relaxation in porcine coronary arteries.
    Hayashi T; Ishikawa T; Kuzuya M; Naito M; Yamada K; Asai K; Hidaka H; Iguchi A
    Heart Vessels; 1994; 9(6):283-91. PubMed ID: 7883650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of endomorphins, endogenous opioid peptides in the brain, on human low density lipoprotein oxidation.
    Lin X; Xue LY; Wang R; Zhao QY; Chen Q
    FEBS J; 2006 Mar; 273(6):1275-84. PubMed ID: 16519691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)-induced oxidation.
    Meyer DF; Mayans MO; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):417-26. PubMed ID: 7654177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.